Drugs / Apitox
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT03710655 | Apr → Aug 2019 | multiple sclerosis | Apimeds, Inc. | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01112722 Comparator | Dec 2013 → Nov 2016 | osteoarthritis, knee | Apimeds, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Apitox | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01112722 ↗ |